175 related articles for article (PubMed ID: 26180003)
1. Dual Cyclooxygenase and Carbonic Anhydrase Inhibition by Nonsteroidal Anti-Inflammatory Drugs for the Treatment of Cancer.
De Monte C; Carradori S; Gentili A; Mollica A; Trisciuoglio D; Supuran CT
Curr Med Chem; 2015; 22(24):2812-8. PubMed ID: 26180003
[TBL] [Abstract][Full Text] [Related]
2. Dual carbonic anhydrase--cyclooxygenase-2 inhibitors.
Dogné JM; Thiry A; Pratico D; Masereel B; Supuran CT
Curr Top Med Chem; 2007; 7(9):885-91. PubMed ID: 17504133
[TBL] [Abstract][Full Text] [Related]
3. Dual Human Carbonic Anhydrase/Cyclooxygenase-2 Inhibitors: A Promising Approach for Cancer Treatment.
Mahboubi-Rabbani M; Zarghi A
Anticancer Agents Med Chem; 2021 Oct; 21(16):2163-2180. PubMed ID: 33511940
[TBL] [Abstract][Full Text] [Related]
4. The cyclooxygenase-2 inhibitor celecoxib is a potent inhibitor of human carbonic anhydrase II.
Knudsen JF; Carlsson U; Hammarström P; Sokol GH; Cantilena LR
Inflammation; 2004 Oct; 28(5):285-90. PubMed ID: 16134002
[TBL] [Abstract][Full Text] [Related]
5. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition.
Weber A; Casini A; Heine A; Kuhn D; Supuran CT; Scozzafava A; Klebe G
J Med Chem; 2004 Jan; 47(3):550-7. PubMed ID: 14736236
[TBL] [Abstract][Full Text] [Related]
6. COX-2 selective inhibitors, carbonic anhydrase inhibition and anticancer properties of sulfonamides belonging to this class of pharmacological agents.
Supuran CT; Casini A; Mastrolorenzo A; Scozzafava A
Mini Rev Med Chem; 2004 Aug; 4(6):625-32. PubMed ID: 15279596
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT
Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety.
Sethi KK; Vullo D; Verma SM; Tanç M; Carta F; Supuran CT
Bioorg Med Chem; 2013 Oct; 21(19):5973-82. PubMed ID: 23965175
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Management of Rheumatoid Arthritis.
Akgul O; Di Cesare Mannelli L; Vullo D; Angeli A; Ghelardini C; Bartolucci G; Alfawaz Altamimi AS; Scozzafava A; Supuran CT; Carta F
J Med Chem; 2018 Jun; 61(11):4961-4977. PubMed ID: 29746127
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibition: insight into non-COX-2 pharmacological effect of some coxibs.
Dogné JM; Thiry A; Supuran CT
Curr Pharm Des; 2008; 14(7):679-84. PubMed ID: 18336314
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy.
Nocentini A; Moi D; Balboni G; Salvadori S; Onnis V; Supuran CT
Bioorg Chem; 2018 Apr; 77():633-639. PubMed ID: 29502024
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors.
Akocak S; Lolak N; Nocentini A; Karakoc G; Tufan A; Supuran CT
Bioorg Med Chem; 2017 Jun; 25(12):3093-3097. PubMed ID: 28400084
[TBL] [Abstract][Full Text] [Related]
13. Discovery of potent anti-convulsant carbonic anhydrase inhibitors: Design, synthesis, in vitro and in vivo appraisal.
Mishra CB; Kumari S; Angeli A; Bua S; Buonanno M; Monti SM; Tiwari M; Supuran CT
Eur J Med Chem; 2018 Aug; 156():430-443. PubMed ID: 30015076
[TBL] [Abstract][Full Text] [Related]
14. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A
J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095
[TBL] [Abstract][Full Text] [Related]
15. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitory activity of sulfonamides and carboxylic acids incorporating cyclic imide scaffolds.
Abdel-Aziz AA; El-Azab AS; Ceruso M; Supuran CT
Bioorg Med Chem Lett; 2014 Nov; 24(22):5185-9. PubMed ID: 25442309
[TBL] [Abstract][Full Text] [Related]
17. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
[TBL] [Abstract][Full Text] [Related]
18. Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action.
Havránková E; Csöllei J; Vullo D; Garaj V; Pazdera P; Supuran CT
Bioorg Chem; 2018 Apr; 77():25-37. PubMed ID: 29324250
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel isoindoline-1,3-dione-based oximes and benzenesulfonamide hydrazones as selective inhibitors of the tumor-associated carbonic anhydrase IX.
Abdel-Aziz AA; El-Azab AS; Abu El-Enin MA; Almehizia AA; Supuran CT; Nocentini A
Bioorg Chem; 2018 Oct; 80():706-713. PubMed ID: 30064081
[TBL] [Abstract][Full Text] [Related]
20. Suppression of adjuvant-induced arthritic bone destruction by cyclooxygenase-2 selective agents with and without inhibitory potency against carbonic anhydrase II.
Katagiri M; Ogasawara T; Hoshi K; Chikazu D; Kimoto A; Noguchi M; Sasamata M; Harada S; Akama H; Tazaki H; Chung UI; Takato T; Nakamura K; Kawaguchi H
J Bone Miner Res; 2006 Feb; 21(2):219-27. PubMed ID: 16418777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
